Radiological characterization, one of the key factors for any successful decommissioning project for a nuclear facility, is defined as a systematic identification of the types, quantities, forms, and locations of radioactive contamination within a facility. This characterization is an essential early step in the development of a decommissioning plan, in particular during transition period after permanent shutdown of the facility, and also to be used for classification of decommissioned radioactive wastes so that their disposal criteria can be met. Therefore, the characterization should be well planned and performed. In the transition period, the characterization information developed during the operational phase is usually reexamined with respect to the applied assumptions, the actual status of the facility after shutdown, the accuracy of the required measurements and changes in its radiological properties to support the development of the final decommissioning plan. Based on some national (Korean, USA’s and Japanese) laws including the related regulations, and some related documents published by OECD/NEA, IAEA, and ASTM, key elements of radiological characterization, which should be developed in the transition period, could be proposed as the followings. The key elements might be an operational history including facility operation history and contamination by events and/or accidents, radiological inventory of the facility and site area, characterization survey including in-situ survey and/or sampling and analyses, radiological mapping (which is able to identify radiological contamination levels of SSCs, and the facility area and, if contamination may be suspected, the surroundings) with tabulating, residual radioactivity (or derived concentration guideline levels) of selected major radionuclides for remediation of the site, (retainable and retrievable) recording, and quality control and quality assurance. In review process of the operational history, interviews of current or former long-tenured knowledgeable employees of the facility should be conducted to identify conditions that may have been missing from the records.

Chlorella gloriosa (Chlorellaceae, Trebouxiophyceae) was isolated from seawater off the coast of the Dokdo Islands in Korea. An axenic culture was established using the streak-plate method on f/2 agar media supplemented with antibiotics, allowing identification of the isolate by morphological, molecular, and physiological analyses. The morphological characteristics observed by light and electron microscopy revealed typical morphologies of C. gloriosa species. The molecular phylogenetic inference drawn from the small-subunit 18S rRNA sequence verified that the microalgal strain belongs to C. gloriosa. Additionally, gas chromatography-mass spectrometry analysis showed that the isolate was rich in nutritionally important omega-3 and -6 polyunsaturated fatty acids and high-performance liquid chromatography analysis revealed that the high-value antioxidants lutein and violaxanthin were biosynthesized as accessory pigments by this microalga, with arabinose, galactose, and glucose as the major monosaccharides. Therefore, in this study, a Korean marine C. gloriosa species was discovered, characterized, and described, and subsequently added to the national culture collection.

This study was performed to investigate the effects of Needle Electrode Electrical Stimulation(NEES) on ischemia-induced cere˗ brovascular accidents. After obstruction and reperfusion of arteries in white mice, the amounts of necrosis and inflammation related sub˗ stances Bax, IL-6, Caspase-3, and COX-2 were measured in neurons of the fore-brain. The following results were obtained. This study used 21 male specific pathogen free(SPF) SD rats, 8 weeks of age and approximately 300g in weight. Each exposed artery was completely occluded with non-absorbent suture thread and kept in that state for 5 minutes. The sutures were then removed to allow reperfusion of blood. Test group is control group(common carotid artery occlusion models), a GI(underwent common carotid artery occlusion), and NEES(underwent NEES after artery occlusion). The GI and NEES groups were given 12, 24, or 48 hours of reperfusion before NEES. NEES device(PG6, ITO, Japan, 9V, current, 2Hz) was used to stimulate the bilateral acupoint ST36 of the SD rats for 30 minutes while they were sedated with 3% isoflurane. An immuno-his˗ tochemistry test was done on the forebrains of the GI induced rats. Both Bax and Caspase-3 immuno-reactive cells, related to apoptosis, were greater in the GI than the NEES group. Cox-2 and IL-6 immuno-reactive cells, related to inflammation, were greater in the GI and NEES groups than the control group. We can expect that applying NEES after ischemic CVA is effective for preventing brain cells from being destroyed. And we can conclude NEES should be applyed on early stage of ischemic CVA.

고연소도 경수로사용후핵연료를 이용하여 voloxidation 및 소결 열처리 공정으로부터 세슘의 시간에 따른 방출 거동을 실험적으로 평가하였다. 사용후핵연료 voloxidation 공정에서는 fragment 형태의 시편을 사용하여 최대 의 산화 및 환원 분위기에 따른 세슘 방출 거동을 상호 비교하였으며, 소결 공정에서는 압분체를 이용하여 4% H2/Ar 환원분위기 에서 열처리 온도 변화에 따른 세슘방출 특성 변화를 분석하였다. 산화 분위기에서 fragment 형태의 사용후핵연료로부터 세슘 방출 온도 구간은 였으며, 환원 분위기에서 압분체로부터 방출 온도 구간은 로서, 산화에 의한 사용후핵 연료의 분말화가 세슘 방출 거동에 영향을 미치는 것으로 나타났다. 아울러 사용후핵 연료로부터 세슘 방출 거동에 영향을 미치는 주요 인자는 사용후핵 연료내 세슘 화합물의 화학적 형태뿐만 아니라 결정립 및 핵연료 표면으로의 확산 속도에 지배를 받음을 알 수 있었다.

사용후핵연료의 건식 재가공을 위한 핵연료 원격 제조공정중 분말제조를 위한 산화 및 OREOX(산화 환원공정)열처리 공정으로부터 및 핵분열기체의 방출거동을 정량적으로 평가하였다. 특히 사용후핵연료의 평균 연소도가 범위내에서 연소도 변화에 따른 핵분열기체의 방출 분율은 측정한 실험결과와 ORIGEN 코드로부터 계산된 초기 inventory를 상호 비교하여 구하였다. 1차 산화공정(voloxidation)에서 및 의 시간에 따른 방출거동은 핵연료의 으로의 분말화 정도와 밀접한 관련이 있는 것으로 보이며, 입계(grain-boundary)에 분포된 핵분열기체가 대부분 방출되는 것으로 여겨진다. 산화분말을 이용한 OREOX 공정으로부터 핵분열기체의 높은 방출율은 의 환원공정에서 온도 증가에 의한 기체 확산 및 으로의 환원에 의한 U 원자 이동성 증가에 의존하며 주로 inter-grain 및 intra-grain에 분포된 핵분열기체가 방출된 것으로 판단된다. 일차 산화공정시 및 핵분열기체의 방출 분율은 핵 연료 연소도가 증가함에 따라 높게 나타났고 방출 분율 범위는 총 inventory의 정도며, 산화분말의 OREOX 공정처리시 잔류 핵분열기체 대부분이 방출되는 것으로 보인다. 아울러 사용후핵 연료로부터 핵분열기체의 제거를 위해서는 고온 환원분위기보다는 산화에 의한 분말화가 더 효과적인 것으로 여겨진다.

Early growth response 1 (Egr1) is a zinc-finger transcription factor to direct second-wave gene expression leading to cell growth, differentiation and/or apoptosis. While it is well-known that Egr1 controls transcription of an array of targets in various cell types, downstream target gene(s) whose transcription is regulated by Egr1 in the uterus has not been identified yet. Thus, we have tried to identify a list of potential target genes of Egr1 in the uterus by performing multi-step in silico promoter analyses. Analyses of mRNA microarray data provided a cohort of genes (102 genes) which were differentially expressed (DEGs) in the uterus between Egr1(+/+) and Egr1(–/–) mice. In mice, the frequency of putative EGR1 binding sites (EBS) in the promoter of DEGs is significantly higher than that of randomly selected non-DEGs, although it is not correlated with expression levels of DEGs. Furthermore, EBS are considerably enriched within –500 bp of DEG’s promoters. Comparative analyses for EBS of DEGs with the promoters of other species provided power to distinguish DEGs with higher probability as EGR1 direct target genes. Eleven EBS in the promoters of 9 genes among analyzed DEGs are conserved between various species including human. In conclusion, this study provides evidence that analyses of mRNA expression profiles followed by two-step in silico analyses could provide a list of putative Egr1 direct target genes in the uterus where any known direct target genes are yet reported for further functional studies.